The global leukemia therapeutics market is poised for substantial growth in the coming decade, driven by advances in treatment technologies, increasing awareness of target-specific therapies, and the growing prevalence of leukemia. With a projected compound annual growth rate (CAGR) of 6.6%, the market is expected to surge from USD 17.4 billion in 2025 to USD …